Safety and immunogenicity of a novel hexavalent group B streptococcus conjugate vaccine in healthy, non-pregnant adults: a phase 1/2, randomised, placebo-controlled, observer-blinded, dose-escalation trial - The Lancet

Safety and immunogenicity of a novel hexavalent group B streptococcus conjugate vaccine in healthy, non-pregnant adults: a phase 1/2, randomised, placebo-controlled, observer-blinded, dose-escalation trial  The Lancet

Comments

Popular posts from this blog

Advanced Heart Failure Therapies for Adults With Congenital Heart Disease: JACC State-of-the-Art Review

Numbness in the hands: Causes and treatments

Jaw Pain and Heart Attack: Understanding the Connection and Symptoms